Sevion Therapeutics Inc (OTCBB - OTCQB:SVON)

Data as of Dec 24
 +0.04 / +3.85%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Sevion Therapeutics, Inc. is a development stage company, which develops cancer therapeutics products. It has developed eukaryotic translation initiation Factor 5A technology to regulate cell death and survival. The company focuses on portfolio with other potential eukaryotic translation initiation Factor 5A applications in cancer, inflammation and ischemia. It has developed therapeutic candidate, SNS01-T for the potential treatment of multiple myeloma. The company was founded on September 30, 1999 and is headquartered in Bridgewater, NJ.

Contact Information

Sevion Therapeutics, Inc.
721 Route 202/206
Bridgewater New Jersey 08807-1760
P:(908) 864-4444
Investor Relations:



Individual stakeholders20.83%
Mutual fund holders--
Other institutional--

Top Executives

Ronald A. MartellPresident, Chief Executive Officer & Director
James Joseph GrazianoChief Technology Officer
Vaughn V. SmiderDirector & Chief Scientific Officer
Miguel A. de los RíosVice President-Research
Alice S. BexonVice President-Clinical Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.